SB 577 amends Tennessee's TennCare program by shortening the time frame for implementing the annual coverage assessment from seven days to five days. It also establishes limits on hospital payments under specific circumstances, directly affecting TennCare administrators and participating hospitals. The bill changes the timing requirement in Tennessee Code Annotated Section 71-5-2005(d)(2)(D) and became effective April 3, 2025, after being signed by the Governor.
HB 1157, the "Restore Trust in Public Health Messaging Act," requires Tennessee's Department of Health, local health departments, and state executive branch to ensure all public communications about FDA-regulated products (like medications) accurately reflect the FDA-approved or FDA-authorized labels. It prohibits promoting information that conflicts with these labels, including general product categories unless universally true or properly qualified. The law mandates an internal compliance review by July 2025, annual reporting to state officials starting in 2026, and a complaint process for violations with potential penalties. This directly affects state health agencies' public messaging about medical products, aiming to align communications with federal FDA standards.
SB 575 requires all Tennessee hospitals and birthing centers offering labor and delivery services to provide new mothers (and, if possible, a caregiver or family member) with clear information about post-birth warning signs - such as symptoms to watch for and local resources - before discharge. The Tennessee Department of Health must also supply this information to all facilities and make it publicly available on its website. This law directly affects healthcare providers in maternal care and ensures new mothers and their support networks receive standardized, accessible guidance on postpartum health concerns. It revises state law to improve maternal health communication without changing medical standards or treatment protocols.
HB 1169 requires Tennessee's Council on Children's Mental Health to submit annual reports starting June 30, 2026, detailing the statewide mental health system for children. The reports must cover current services (including state/federal programs), gaps in care, and recommendations for better coordination between agencies. The council must gather input from relevant departments (mental health, education, health, etc.) to create a comprehensive overview. These reports will be shared with the governor, legislative leaders, and agency heads. The bill, effective March 28, 2025, updates existing law to ensure regular oversight of children's mental health services.
SB 1031, the "Restore Trust in Public Health Messaging Act," requires Tennessee's health departments and state agencies to align all public communications about FDA-approved drugs and medical products with the FDA's official labels. It directly affects the Tennessee Department of Health, local health departments, and state executive branch employees who share information about medications or health products. The bill prohibits promoting claims that conflict with FDA labels, mandates internal reviews by July 2025, and requires annual compliance reports to the legislature. Violations trigger investigations by the comptroller, with potential penalties for noncompliance. This law aims to ensure state health messaging is scientifically accurate and consistent with federal standards.
SB 321 creates an advisory task force to review and recommend annual adjustments to state reimbursement rates paid to healthcare providers under state contracts. The task force, composed of 6 appointed members (3 by each legislative chamber, representing health professions) plus agency representatives, will assess whether reimbursement rates cover agencies' costs, staff salaries, and administrative expenses for frontline healthcare workers. It must submit annual recommendations by August 1, starting in 2026, focusing on ensuring rates are adequate to support quality care for vulnerable populations. This bill directly affects state-contracted healthcare agencies and providers who serve Medicaid and other state-funded programs.
SB 267 clarifies that medical laboratories operating collection stations in Tennessee do not need an additional license for those stations, regardless of where specimens are transported, provided the laboratory owner retains full ownership and oversight. This directly affects medical laboratories and their collection sites, eliminating redundant licensing requirements. The bill amends Tennessee Code Annotated § 68-29-122 to specify that only non-owner-operated collection stations require a separate license, while all stations must still follow board rules. The change takes effect July 1, 2025, streamlining operations for lab-owned collection points.
SB 522 requires Tennessee's TennCare program to cover diagnosis (including genetic testing) and treatment for Kleefstra syndrome - a rare genetic disorder causing developmental delays, intellectual disability, and physical symptoms - on the same terms as coverage for autism spectrum disorder, Down syndrome, and similar genetic conditions. This mandate applies directly to TennCare enrollees diagnosed with Kleefstra syndrome, ensuring access to therapies, medications, and interventions aimed at improving quality of life. The bill updates TennCare coverage rules to include this condition under existing standards for comparable genetic disorders. It takes effect July 1, 2025.
SB 318, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants sourced from the People's Republic of China or performed there, effective January 1, 2026. It also bans medical and research facilities from using genetic sequencing equipment or software produced by or linked to "foreign adversaries" (defined as nations on U.S. sanctions lists), requiring replacement within 180 days. The bill restricts storage of genetic sequencing data to U.S. geographic locations and prohibits remote access from outside the U.S. without state health commissioner approval. These provisions directly affect health insurers, hospitals, and research facilities operating in Tennessee.
HB 395, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants or post-transplant care if the organ was sourced from China or procured through sale/donation originating in China. It also bans medical and research facilities from using genetic sequencing equipment or software produced by entities linked to "foreign adversaries" (specifically targeting China per the bill's context), requiring replacement within 180 days. Additionally, the bill mandates that all genetic sequencing data must be stored within the United States, with remote access from outside the country prohibited without approval from the state health commissioner. The law takes effect on January 1, 2026, directly affecting health insurers, hospitals, and research facilities operating in Tennessee.
